Over the course of 50 years we have grown to become a global company that develops innovative solutions for our customers, and manages the best interests of our investors, our employees, society and other stakeholders. Read on to discover what we achieved in 2018.

close

About

Chapter preview

The demand for smaller, faster and cheaper semiconductor chips continues to rise, driven by advancements in cloud computing, artificial intelligence, smartphones and the Internet of Things.

MEETING DEMAND

Our technology is the first step towards making it all possible, as our R&D investment in new materials, new products and new processes means we can help our customers develop their technology roadmap, and further extend Moore’s Law.

CREATING RESULTS

In 2018, this led to the introduction of the Synergis ALD tool, which leverages the core technologies from our Pulsar and EmerALD ALD products for high productivity thermal ALD applications. The new Synergis tool allows us to address more ALD applications and therefore increases our served market. Together with our other products and services, this contributed to our strong financial results, which included:

  • net sales of €818 million;
  • bookings of €942 million;
  • operating result of €124 million; and
  • operating cash flow of €137 million.

close

Strategy & business

Chapter preview

We operate in a fast-paced industry that continues to reshape the world, and our innovative technology enables the semiconductor industry to achieve advancements in computing, communications, energy, transportation, medicine and beyond.
To ensure that we can continue to make a difference to our customers, employees, and company stakeholders, in 2018 we concentrated on the following three key elements of our strategy.

INNOVATIVE STRENGTH

In addition to our fundamental R&D efforts, we continuously expand and deepen our strategic cooperation with key customers, suppliers, chemical manufacturers, and research institutes. This approach enables us to remain innovative and swiftly meet the changing demands of our customers.

LEADERSHIP IN DEPOSITION

We are a key player in the deposition equipment segments for ALD and epitaxy, and a focused niche player for PECVD and vertical furnaces. As a leader in the segment, ALD has turned into a key growth driver for our business, from which we support virtually all of the leading customers in the semiconductor industry. Our newest ALD tool, Synergis, is designed to address a wide range of existing and new ALD applications, effectively increasing the market we serve.

OPERATIONAL EXCELLENCE

In addition to our internal optimization programs, we are working with our suppliers to improve fundamental quality through statistical methods and process controls. In addition to addressing the technology needs of our customers, we also focus on further increasing equipment throughput and equipment reliability, thereby lowering the cost per wafer of our wafer processing systems.

close

Performance review

Chapter preview

In 2018, we achieved revenue growth of 11% reaching a record high revenue of €818 million, with sales increasing mainly in the logic, DRAM and analog segments. By industry segment, our 2018 revenue stream was led by memory, closely followed by the logic and foundry segments.

MULTIPLE PRODUCT LINES

While our ALD product lines continued to be our key sales driver in 2018, accounting for more than half of total equipment revenue, our other product lines also contributed strongly. In our epitaxy product line we increased sales, following the strong growth we achieved in 2017, and we saw additional sales increases in PECVD and vertical furnaces.

MARKET GROWTH

Our industry experienced continued growth in 2018, with worldwide semiconductor industry sales increasing by around 14%. This was driven by high memory prices and broad-based electronics demand for cloud services, mobile devices, automotive and industrial applications. These drivers helped the wafer fab equipment market grow by around 10% in 2018.

close

Governance

Chapter preview

Our 2018 sales grew to record levels, reaching €818 million. ALD continued to be the key driver, although the other product lines also made a strong contribution.
We benefited from a further increase in wafer fab equipment spending following the very strong market growth in 2017. Our operating profit increased to €124.3 million from €113.2 million in 2017, while the operating profit margin remained stable.

OTHER DEVELOPMENTS

New bookings increased by 22% in 2018 to €942 million, with equipment bookings for ASMI as a whole led by logic, followed by foundry and then memory. Total research and development (R&D) expenses, excluding impairment charges, decreased by 1% in 2018 compared to 2017, mainly as a result of higher capitalization of development expenses.

close

Financial statements

Chapter preview

Our 2018 sales grew to record levels, reaching €818 million. ALD continued to be the key driver, although the other product lines also made a strong contribution.
We benefited from a further increase in wafer fab equipment spending following the very strong market growth in 2017. Our operating profit increased to €124.3 million from €113.2 million in 2017, while the operating profit margin remained stable.

OTHER DEVELOPMENTS

New bookings increased by 22% in 2018 to €942 million, with equipment bookings for ASMI as a whole led by logic, followed by foundry and then memory. Total research and development (R&D) expenses, excluding impairment charges, decreased by 1% in 2018 compared to 2017, mainly as a result of higher capitalization of development expenses.

close

Other Information

Chapter preview

During 2018, we returned approximately €607 million to shareholders in the form of dividends, share buybacks and the capital return. This was up from €281 million in 2017 and €140 million in 2016.
Over the 2010-2018 period, we returned more than €1.6 billion to the financial markets through dividends, share buybacks, return of capital, and buyback of convertible bonds.

SHAREHOLDER DIVIDEND

Sae laccuptatur ad eum fugita alic tem sam aperum fugiatet harum inisin niscit ipid ut danto ipsam doloria sitas qui nobitaspe nos et, saniae receperatium laut ut quiscitae.

DELIVERING RESULTS

In 2018, we paid a dividend of €0.80 per common share and we will propose to the forthcoming AGM to declare a dividend of €1.00 per share for 2019. The proposed 2019 dividend will mark the ninth consecutive year that we have paid a dividend.

NOTE 13. EMPLOYEE BENEFITS

PENSION PLANS

The Company has retirement plans covering substantially all employees. The principal plans are defined contribution plans, except for the plans of the Company’s operations in the Netherlands and Japan.

Multi-employer plan

There are 149 eligible employees in the Netherlands. These employees participate in a multi-employer union plan (Pensioenfonds van de Metalektro PME) determined in accordance with the collective bargaining agreements effective for the industry in which we operate. This current collective bargaining agreement has ended on May 31, 2018. A negotiation agreement was reached in February 2019 but no new collective bargaining agreement was effective yet. This multi-employer union plan, accounted for as a defined contribution plan, covers approximately 1,300 companies and approximately 145,000 contributing members. Our contribution to the multi-employer union plan was less than five percent of the total contribution to the plan. The plan monitors its risks on a global basis, not by participating company or employee, and is subject to regulation by Dutch governmental authorities. By law (the Dutch Pension Act), a multi-employer union plan must be monitored against specific criteria, including the coverage ratio of the plan’s assets to its obligations. As of January 1, 2015, new pension legislation has been enacted. This legislation results in amongst others, an increase of legally required coverage levels. The coverage percentage is calculated by dividing the funds capital by the total sum of pension liabilities and is based on actual market interest rates. The coverage ratio as per December 31, 2018 of 97.6% (December 31, 2017: 101.6%) is calculated giving consideration to the pension legislation and is below the legally required level. We have however no obligation to pay off any deficits the pension fund may incur, nor do we have any claim to any potential surpluses.

Every company participating in the PME contributes a premium calculated as a percentage of its total pensionable salaries, with each company subject to the same contribution rate. The premium can fluctuate yearly based on the coverage ratio of the multi-employer union plan, for 2018 the contribution percentage was 25.35%. The pension rights of each employee are based upon the employee’s average salary during employment.

Our net periodic pension cost for this multi-employer union plan for any period is the amount of the required employer contribution for that period minus the employee contribution.

Defined benefit plan

The Company’s employees in Japan participate in a defined benefit plan. The Company makes contributions to defined benefit plans in Japan that provide pension benefits for employees upon retirement. These are average-pay plans, based on the employees' years of service and compensation near retirement.

The most recent actuarial valuations of plan assets and the present value of the defined benefit obligation were carried out on December 31, 2018. The present value of the defined benefit obligation and the related current service cost and past service cost were measured using the projected unit credit method. Significant actuarial assumptions for the determination of the defined obligation are discount rate, future general salary increases and future pension increases.

The net liability (asset) of the plan developed as follows:

 December 31,
 20172018
Defined benefit obligations10,16710,502
Fair value of plan assets9,78110,726
Net liability (asset) for defined benefit plans386(224)

The changes in defined benefit obligations and fair value of plan assets are as follows:

 December 31,
 20172018
Defined benefit obligations
Balance January 111,40310,167
Current service cost747735
Interest on obligation5250
Remeasurement result(147)(262)
Benefits paid(926)(914)
Foreign currency translation effect(962)726
Balance December 3110,16710,502
Fair value of plan assets
Balance January 19,9859,781
Interest income4851
Return on plan assets454(8)
Company contribution1,1021,098
Benefits paid(926)(914)
Foreign currency translation effect(882)718
Balance December 319,78110,726

The defined benefit cost consists of the following:

 December 31,
 20172018
Current service cost747735
Net interest costs4(1)
Net defined benefit cost751734
Reclassification to remeasurement866
Remeasurement on net defined benefit for the year(602)(254)
Remeasurement on net defined benefit264(254)
Total defined benefit cost1,015480

The assumptions in calculating the actuarial present value of benefit obligations and net periodic benefit cost are as follows:

 20172018
Discount rate for defined benefit obligations0.50%0.50%
Discount rate for defined benefit cost0.50%0.50%

Assumptions regarding life expectancy are based on mortality tables published in 2014 by the Ministry of Health, Labour and Welfare of Japan.

The main risk on the pension plan relates to the discount rate. The defined benefit obligation is sensitive to a change in discount rates, a relative change of the discount rate of 25 basis points would have resulted in a change in the defined benefit obligation of 2.7%.

The allocation of plan assets is as follows:

 December 31,
 20172018
Cash and cash equivalent951%1491%
Equity instruments1,82719%1,87918%
Debt instruments1,02911%1,0079%
Assets held by insurance company6,83069%7,69172%
Total9,781100%10,726100%

The investment strategy is determined based on an asset-liability study in consultation with investment advisors and within the boundaries given by the regulatory bodies for pension funds.

Equity instruments consist primarily of publicly traded Japanese companies and common collective funds. Publicly traded equities are valued at the closing prices reported in the active market in which the individual securities are traded (level 1). Common collective funds are valued at the published price (level 1) per share multiplied by the number of shares held as of the measurement date. Debt instruments consists of government bonds and are valued at the closing prices in the active markets for identical assets (level 1). Assets held by insurance company consist of bonds and loans, government securities and common collective funds. Corporate and government securities are valued by third-party pricing sources (level 2). Common collective funds are valued at the net asset value per share (level 2) multiplied by the number of shares held as of the measurement date.

The plan assets do not include any of the Company’s shares.

Retirement plan costs

ASMI contributed €1,101 to the defined benefit plan in 2018 (€1,096 in 2017). The Company expects to pay benefits for years subsequent to December 31, 2018 as follows:

Expected contribution defined benefit plan
2019489
2020323
2021377
2022808
2023765
Aggregate for the years 2024-20283,971
Total6,733

The Company does not provide for any significant post-retirement benefits other than pensions.

MANAGEMENT BOARD AND EMPLOYEE AND LONG-TERM INCENTIVE PLAN

The Company has adopted various share plans (e.g. stock option plans, a restricted share plan and a performance share plan) and has entered into share agreements with the Management Board and various employees. Under the stock option plans, the Management Board and employees may purchase per the vesting date a specific number of shares of the Company’s common stock at a certain price. Options are priced at market value in euros or US dollars on the date of grant. Under the restricted share plan, employees receive per the vesting date a specific number of shares of the Company’s common stock. Under the performance share plan, the Management Board receives per the vesting date, and provided the performance criteria have been met, a specific number of shares of the Company’s common stock.

Authority to issue options and shares

By resolution of the Annual General Meeting of Shareholders (AGM) of May 28, 2018, the formal authority to issue options and shares was allocated to the Management Board subject to the approval of the Supervisory Board. This authority is valid for 18 months and needs to be refreshed by the 2019 AGM to allow the continued application of the long-term incentive (LTI) plans beyond November 28, 2019.

The ASMI 2014 long-term incentive plan for employees (ELTI) is principally administered by the Management Board and the ASMI 2014 Long-Term Incentive Plan for members of the Management Board (MLTI) is principally administered by the Supervisory Board. This complies with applicable corporate governance standards. However, the Supervisory Board has no power to represent the Company. For external purposes the Management Board remains the competent body under both LTI plans. The LTI plans envisage that the Supervisory Board, or in the case of the ELTI the Management Board with the approval of the Supervisory Board, will determine the number of options and shares to be granted to the Management Board members and to employees.

Capital repayment

On August 10, 2018, ASMI distributed €4.00 per common share to its shareholders through a tax efficient repayment of capital. The ex-date of the distribution was August 7, 2018. This capital repayment was previously approved by the 2018 AGM. The Management Board of ASMI and the Supervisory Board of ASMI decided to apply a theoretical adjustment ratio of 0.91821713 to the outstanding options and restricted shares granted to employees including members of the Management Board.

2011 Long-Term Incentive Plan

In 2011 a stock option plan was adopted. In this plan to limit potential dilution, the amount of outstanding (vested and non-vested) options granted to the Management Board and to other employees will not exceed 7.5% of the issued ordinary share capital of ASMI. The stock option plan 2011 consists of two sub-plans: the ASMI stock option plan for employees (ESOP) and the ASMI stock option for members of the Management Board (MSOP).

For employees and existing Management Board members the grant date for all options granted is December 31 of the relevant year. In each of these situations, the three-year vesting period starts at the grant date. The exercise price in euros of all options issued under the ESOP and the MSOP is determined on the basis of the market value of the ASMI shares at (i.e. immediately prior to) the grant date.

The exercise period is four years starting at the third anniversary of the grant date.

The following table is a summary of changes in options outstanding under the 2011 and previous long-term incentive plan:

Euro-plansUS dollar-plans
Number of optionsWeighted average exercise price in €Number of optionsWeighted average exercise price in US$
Balance January 1, 20171,295,13221.6399916.62
Options forfeited
Options expired(2,179)21.13
Options exercised(626,444)21.14(999)16.62
Balance December 31, 2017666,50922.09
Adjustment following capital repayment53,455
Options forfeited
Options expired(8,037)18.96
Options exercised(260,757)18.70
Balance December 31, 2018451,17021.48

The total intrinsic value of options exercised was €4,817 for the year ended December 31, 2018 (2017: €13,292). In 2018 treasury shares have been sold for the exercise of 258,688 options.

On December 31, 2018, options outstanding and options exercisable classified by range of exercise prices are:

 Options outstandingOptions exercisable
Range of exercise pricesNumber outstandingWeighted average remaining contractual lifeWeighted average exercise priceNumber exercisableWeighted average exercise price
Euro plansIn yearsIn EURIn EUR
€1.00-15.00
€15.01-20.00
€20.01-25.00451,1701.621.48451,17021.48
€1.00-25.00451,1701.621.48451,17021.48

At December 31, 2018, the aggregate intrinsic value of all options outstanding and exercisable under these plans is €16,332.

Under these plans, no more options to purchase shares can be issued. Under the various stock option plans a total of 451,170 options to purchase common stock were outstanding at December 31, 2018, expiring at various dates through 2020.

2014 Long-Term Incentive Plan

In 2014 a new long-term incentive plan was adopted. In the new plan to limit potential dilution, the amount of outstanding (vested and non-vested) options and shares granted to the Management Board and to other employees will not exceed 5% of the issued ordinary share capital of ASMI. The new long-term incentive plan 2014 consists of two sub-plans: the ELTI and the MLTI.

Options and performance shares are issued to Management Board members and restricted shares are issued to employees once per annum on the date following the publication of the first-quarter results of the relevant year. Possible grant to newly-hired employees can be issued once a quarter, on the date following the publication of the financial results of the relevant quarter. The number of options and shares outstanding under the long-term incentive plans or under any other plan or arrangement in aggregate may never exceed 5% of ASMI’s share capital. In accordance with the ASMI remuneration policy, an exception is made for a transition period of four years, during which the dilution may exceed 5% but will not exceed 7.5%.

Performance and restricted shares outstanding

The following table is a summary of changes in performance shares and restricted shares outstanding under the 2014 long-term incentive plan.

Number of performance sharesNumber of restricted sharesStatusFair value at grant date (weighted average)
Balance January 1, 201729,645307,505
Shares granted, employees149,197Unconditional€52.29
Shares granted, Management Board17,413Conditional€51.75
Shares vested(118,317)
Shares forfeited(31,850)
Balance December 31, 201747,058306,535
Adjustment following capital repayment5,31228,582
Shares granted, employees174,951Unconditional€49.90
Shares granted, Management Board25,573Conditional€49.78
Shares granted, Management Board2,274Unconditional€43.21
Shares vested(15,268)(147,523)
Shares forfeited(21,357)
Balance December 31, 201864,949341,188

In 2018, treasury shares were sold for the vesting of 162,791 restricted shares.

Options outstanding

The following table is a summary of changes in options outstanding under the 2014 long-term incentive plan.

Number of optionsExercise price in €Fair value at grant date
Balance January 1, 2015
Options granted, April 24, 201542,65944.24€17.33
Balance December 31, 201542,659
Options granted, April 22, 201662,55537.09€12.64
Balance December 31, 2016105,214
Options granted, April 21, 201724,96351.55€14.57
Balance December 31, 2017130,177
Adjustment following capital repayment11,593
Balance December 31, 2018141,770

The cost relating to stock options is measured at fair value on the grant date. The fair value for the stock options granted in 2018 was determined using the Black-Scholes option valuation model with the following weighted average assumptions:

 2018
Expected life (years)7
Risk-free interest rate1.05%
Dividend yield1.80%
Expected volatility30.47%
Exercise price€57.25
Fair value per grant date€14.90

The expected volatility measured at the standard deviation of continuously compounded share returns is based on statistical analysis of daily share prices over the last seven years.

At December 31, 2018, the aggregate intrinsic value of all options outstanding under the 2014 long-term incentive plan is €5,132.

Share-based payments expenses

The grant date fair value of the stock options, the restricted shares and the performance shares is expensed on a straight-line basis over the vesting period, based on the Company’s estimate of stock options, restricted shares and performance shares that will eventually vest. The impact of the true up of the estimates is recognized in the consolidated statement of profit or loss in the period in which the revision is determined. We recorded compensation expenses of €4,817 for 2018 (2017: €7,801).

 

TAKING THE NEXT LEAP FORWARD

Over the past 50 years we have grown to become a leading global supplier
of semiconductor wafer processing equipment. A company that develops
innovative process solutions for our customers, and manages itself in the best
interests of our investors, our employees, society, and other stakeholders.

Yet now is the time to enter a new era of innovation, to embark on the next
phase of growth. We understand that this requires commitment and strength
across many areas. From innovation in R&D, to advancing new technologies
and addressing new applications. From developing our people, to creating
even stronger relationships with key customers.

This is how we will take the next leap forward.

The

Of new materials

R

i

s

e

ROADMAP TO THE FUTURE

Our roadmap to the future will enable us to not only
achieve our next phase of growth, it will ensure we
can continue to help our customers achieve their
technology roadmaps for next-generation devices.

INNOVATION

Our technology helps drive innovation, increasing the number of scientific breakthroughs, many of which are achieved from our advanced process equipment that deposits new materials with precision and productivity, positively benefiting society in sectors from healthcare and education, to transport and energy.

SCALING

For semiconductor manufacturers, scaling chips
to smaller dimensions is an ongoing challenge.
Our innovations and equipment are vital in helping make many of these transitions happen.

EFFICIENCY

Striving for efficiency ensures that our
customers get the products, services,
and results they expect. Intensifying
our focus on efficiency will make us a
stronger company, ready to take the
next leap forward.

The

That
matters

m

i

x

Multinational

We are a multinational company that
embraces diversity in every sense
of the word. With 29 different
nationalities working across the
company, we combine our talents
to drive innovation.

INTELLIGENCE

Achieving our ambitions takes intelligence, knowledge, skill,
determination, and dedication. And it is this combination of
qualities that we nurture in our people.

XTRAORDINARY

Our goal is to impact tomorrow’s generation
as positively as we’ve impacted today’s.
Making this happen takes the xtraordinary
talent of our people, who work together
to drive innovation and deliver excellence.

Expanding the

c

o

r

e

COLLABORATION

Collaboration is fundamental to our
continued success; from working
with our customers to optimize our
equipment and processes to enable
their technology roadmaps, to
creating partnerships on cutting-edge
research and development.

OPERATIONAL EXCELLENCE

Operational excellence is one of the essential
pillars of our strategy, which enables us to provide
our customers with the high-quality, leading-edge
products and services they demand.

R&D

R&D is central to our development,
leading to new device architectures,
new materials, and new processes
that strengthen our competitive
positioning and enable our customers
to deliver the next-generation chips.

Extending

By extending our technological scope with a
more diverse product portfolio, we can help our
customers continue to advance their business
while growing our own in new market segments.

Moore with

l

e

s

s

LONG-TERM VALUE

We create long-term value for our
stakeholders in a variety of ways.
From working with our customers
to develop innovative solutions, to
ensuring value creation growth
and positive investor returns.

ENVIRONMENT

We are committed to positively
contributing to society and
reducing our impact on the
environment. Only then can
we truly say we are helping
create more with less.

SUSTAINABILITY

We believe sustainability takes many forms.
From developing sustainable technology
roadmaps for our customers, to creating
a sustainable living environment for all.

SAFETY

Safety is a front-line requirement,
which is why our ZERO HARM!
policy outlines our vision on product
safety, and our CR policy lays out
our commitment and expectations
towards health and safety.